FDA APPROVED DRUGS AND RECALLS

RX NEWS

RX NEWS


The Division of Drug Information (DDI)- serving the public by providing information on human drug products and drug product regulation by FDA.


The U.S. Food and Drug Administration approved Nuplazid (pimavanserin) tablets, the first drug approved to treat hallucinations and delusions associated with psychosis experienced by some people with Parkinson’s disease.

Hallucinations or delusions can occur in as many as 50 percent of patients with Parkinson’s disease at some time during the course of their illness. People who experience them see or hear things that are not there (hallucinations) and/or have false beliefs (delusions). The hallucinations and delusions experienced with Parkinson’s disease are serious symptoms, and can lead to thinking and emotions that are so impaired that the people experiencing them may not relate to loved ones well or take appropriate care of themselves.  

As with other atypical antipsychotic drugs, Nuplazid has a Boxed Warning alerting health care professionals about an increased risk of death associated with the use of these drugs to treat older people with dementia-related psychosis. No drug in this class is approved to treat patients with dementia-related psychosis.

In clinical trials, the most common side effects reported by participants taking Nuplazid were: swelling, usually of the ankles, legs, and feet due to the accumulation of excessive fluid in the tissue (peripheral edema); nausea; and abnormal state of mind (confused state).

 

For more information, please visit: Nuplazid.


05/03/2016 10:31 AM EDT
As a precaution, CRF Frozen Foods of Pasco, Washington is expanding its voluntary recall of frozen organic and traditional fruits and vegetables. We are performing this voluntary recall in cooperation with the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) because these products have the potential to be contaminated with Listeria monocytogenes.

05/02/2016 01:40 PM EDT
All lots of Giant Eagle brand Walnut Delight and Pecan Tassie cookies prepared and sold from the Bakery department inside Giant Eagle and Market District supermarkets with sell by dates through May 3, 2016 have been voluntarily recalled by Giant Eagle due to an undeclared milk allergen. People who have an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if they consume these products.

05/02/2016 01:37 PM EDT
CSM Bakery Solutions (Atlanta, GA) is voluntarily recalling the following products: Safeway 8″ Single Layer Red Velvet Cake, ACME 12″ Decorated Chocolate Chip Cookie, Jewel 12″ Decorated Chocolate Chip Cookie. People who have an allergy or severe sensitivity to peanut run the risk of a serious or life-threatening allergic reaction if they consume these products.

04/30/2016 09:02 AM EDT
The Republic of Tea is dedicated to the health and wellness of each and every citizen (customer). As such, we are issuing a voluntary recall of our Organic Turmeric Ginger Green Tea in response to a possible health risk.

04/29/2016 12:55 PM EDT
Bakery Express of Central FL., Inc of Orlando, Florida is recalling select 7-ELEVEN FRESH TO GO cookies, because they may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

04/29/2016 04:42 PM EDT
7-Eleven, Inc. of Irving, TX is recalling fully baked chocolate chunk, sugar and oatmeal raisin cookies produced by CSM Bakery Solutions frozen cookie pucks because they may contain undeclared peanut. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products.

04/29/2016 09:59 PM EDT
Making It A Lifestyle, L.L.C. is voluntarily recalling all lots of 3rd Degree, Black Gold X Advanced and Black Label X capsule form supplements to the consumer level. The products have been found to contain undeclared sibutramine and sildenafil.

04/28/2016 05:04 PM EDT
World’s Choice Products, Inc. of San Diego, CA, is recalling the following products: 32 fluid ounce Supreme Elixir drink, 32 fluid ounce Kid’s Juice, 1 pound and 8 ounce Xtreme Fiber Detox. The recall was initiated because the products contain undeclared whey protein, which contains the allergens of milk and soy lecithin.

The U.S. Food and Drug Administration today approved the first generic version of Crestor (rosuvastatin calcium) tablets for the following uses:  

  • in combination with diet for the treatment of high triglycerides (hypertriglyceridemia) in adults;
  • in combination with diet for treatment of patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia), a disorder associated with improper breakdown of cholesterol and triglycerides;
  • either alone or in combination with other cholesterol treatment(s) for adult patients with homozygous familial hypercholesterolemia, a disorder associated with high low-density lipoprotein (LDL) cholesterol.

In the clinical trials for Crestor, the most common side effects reported by participants taking Crestor included headache, pain in muscles (myalgia), abdominal pain, abnormal weakness (asthenia), and nausea.

Rosuvastatin calcium should not be used in women who are pregnant or may become pregnant as it may cause fetal harm. Women who require treatment with rosuvastatin should be advised not to nurse their infants.

For more information, please visit: rosuvastatin.


Drug Information Update – New Drug Safety Communication on Brintellix (vortioxetine)



The U.S. Food and Administration (FDA) has approved a brand name change for the antidepressant Brintellix (vortioxetine) to decrease the risk of prescribing and dispensing errors resulting from name confusion with the blood-thinning medicine Brilinta (ticagrelor). The new brand name of the drug will be Trintellix, and it is expected to be available starting in June 2016. No other changes will be made to the label or packaging, and the medicine is exactly the same.

Because of the lag time associated with manufacturing bottles with the new brand name, health care professionals and patients may continue to see bottles labeled with the brand name Brintellix during the transition period.

Health care professionals should check carefully to make sure they have prescribed or dispensed the correct medicine. During the transition to the new name change from Brintellix to Trintellix, prescribers can reduce the risk of name confusion by including the generic name of the medication they are ordering, in addition to the brand name and indication for use. Patients should make sure they have received the correct medicine. Trintellix tablets will look the same as the Brintellix tablets. Those having any questions or concerns should talk to their prescriber or pharmacist.

Brintellix/Trintellix (vortioxetine) is used to treat a certain type of depression called major depressive disorder in adults. It is in a class of antidepressants called serotonin reuptake inhibitors (SSRIs) that work by affecting chemicals in the brain that may become unbalanced.

For more information, please visit: Brintellix.


Update: Ongoing Zika Virus Transmission — Puerto Rico, November 1, 2015–April 14, 2016
Emilio Dirlikov, PhD; Kyle R. Ryff, MPH; Jomil Torres-Aponte, MS; et al.
MMWR Morb Mortal Wkly Rep 2016;65:(Early Release)

During November 1, 2015–April 14, 2016, a total of 6,157 specimens from suspected Zika virus–infected patients from Puerto Rico were evaluated, and 683 (11%) had laboratory evidence of current or recent Zika virus infection. Of the 683, there were 65 (10%) symptomatic pregnant women who tested positive for Zika. A total of 17 (2%) patients required hospitalization, including five patients with suspected Guillain-Barré syndrome. One patient died after developing severe thrombocytopenia. The public health response in Puerto Rico includes increased capacity to test for Zika virus, preventing infection in pregnant women, monitoring infected pregnant women and their fetus for adverse outcomes, controlling mosquitos, and assuring the safety of blood products.

MMWR  PDF

END REPORT….

Advertisements

Revelation 19:16 On his robe and on his thigh he has this name written: KING OF KINGS AND LORD OF LORDS. This blog is to present Up To Date Prophetic News. My prayer is that this blog will bring others to know Jesus as their Savior if they do not know him the King of Kings and Lord of Lords.

Tagged with: , ,
Posted in 2016, AMERICA, FDA, GOVERNMENT, Signs of the Times, WORLDNEWS

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 412 other followers

ARHCIVES
UPDATES
May 2016
S M T W T F S
« Apr   Jun »
1234567
891011121314
15161718192021
22232425262728
293031  

Error: Twitter did not respond. Please wait a few minutes and refresh this page.

Error: Twitter did not respond. Please wait a few minutes and refresh this page.

Visit Us
%d bloggers like this: